Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction [1] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 25, 2005, Pages 2647-2648

  Chua, Doson ^a   Lo, Christopher ^b   Babor, Elisa Maria ^a   Sabatine, Marc S ^c   Cannon, Christopher P ^c   Braunwald, Eugene ^c  

^a ST PAUL S HOSPITAL   (Canada)

^b Langley Memorial Hospital   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; METOPROLOL; RETEPLASE; TENECTEPLASE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADD ON THERAPY; ANGIOGRAPHY; CLINICAL TRIAL; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR PATENCY; CORONARY ARTERY BLOOD FLOW; DRUG COMBINATION; DRUG EFFECT; NOTE; OUTCOME ASSESSMENT; RECURRENT DISEASE;

ASPIRIN; CORONARY CIRCULATION; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HEPARIN; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; RECURRENCE; TICLOPIDINE; VASCULAR PATENCY;

EID: 22444449608     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200506233522518     Document Type: Letter

References (0)